Workspan Daily article Strategies to Deliver Diabetes Support and Solutions for Employees, Workspan Daily article Fifty-one percent of employers in a recent benefits study cited glucagon-like peptide-1 (GLP-1) diabetes and weight-loss medications as the top driver of prescription drug spend, surpassing even cancer and autoimmune treatments
Even if solid pharmacological options emerge for treating SPD, its important for dermatologists to be aware that SPD and other BFRBs can be a symptom of other dermatological disorders, autoimmune problems, obsessive-compulsive disorder, and substance abuse disorders, among others.
van der Vusse GJ, van Bilsen M, Glatz JF: Cardiac fatty acid uptake and transport in health and disease
This protective effect is mainly advantageous for type 2 diabetes, where beta cells are still present but not functioning well
However, this represents a double-edged sword
It is designed to target stubborn fat deposits that dont respond to diet and exercise